Terapia Génica y Celular, Cultivo Celular, Stem cells, Producción y purificación de virus, Biología molecular, Expresión y purificaciób_: de proteínas recombinantes, Extremofilos,

MENTORING STUDENTS

Name: Paulina Soto Farias
Degree Granted: Undergraduate and Master’s Degree
Program: Master’s in engineering sciences, with a specialization in Chemical and Civil Engineering in
Biotechnology and Civil Engineering in Biotechnology
Thesis title: Adaptation of Melanoma Cell Lines to Suspension Cultures Using Microcarriers for the Production of Immunogenic Lysates for Application in Human Melanoma Vaccines
Period: March 2024 - Present
Institution: Universidad de Chile and Oncobiomed.
Role: Co-advisor

Name: Lilier Simons
Degree Granted: Undergraduate and Master’s Degree
Program: Master’s in engineering sciences, with a specialization in Chemical and Civil Engineering in Biotechnology and Civil Engineering in Biotechnology
Thesis title: To be defined
Period: March 2024 - Present
Institution: Universidad de Chile
Role: Co-advisor

Name: Agustín Avilés
Degree Granted: Undergraduate Degree
Program: Civil Engineering in Biotechnology
Thesis title: Design and Prototyping of a Cultivation and Separation System for Mesenchymal Cells
Period: December 2024 - Present
Institution: Universidad de Chile
Role: Co-advisor

Name: Vicente Mérida
Degree Granted: Undergraduate and Master’s Degree
Program: Master’s in engineering sciences, with a specialization in Chemical and Civil Engineering in Biotechnology and Civil Engineering in Biotechnology
Thesis title: Design, Scaling, and 3D Printing of a Mesenchymal Stem Cell Separation System for Suspension Cultures
Period: March 2024 – Present
Institution: Universidad de Chile
Role: Co-advisor

Name: Pilar Vera
Degree Granted: Undergraduate and Master’s Degree
Program: Civil Engineering in Biotechnology and Master’s in engineering sciences, with a specialization in Chemical and Civil Engineering in Biotechnology and Civil Engineering in Biotechnology
Thesis title: Optimization of Suspension Culture in Xeno-Free Conditions for Wharton’s Jelly Stem Cells
Period: March 2024 - Present
Institution: Universidad de Chile
Role: Co-advisor

Name: Felipe Matus
Degree Granted: Undergraduate and Master’s Degree
Program: Master’s in engineering sciences, with a specialization in Chemical and Civil Engineering in Biotechnology and Civil Engineering in Biotechnology
Thesis title: Optimization of Stem Cell Harvesting in Suspension Cultures
Period: August 2022 – March 2025
Institution: Universidad de Chile
Role: Co-advisor

Name: Temistocles Molina
Degree Granted: Civil Engineering in Biotechnology, 2023
Program: Civil Engineering in Biotechnology
Thesis title: Optimization of Cultivation Conditions and Improvement of Proliferation of Mesenchymal Stem Cells Derived from Human Adipose Tissue
Period: January 2022 - January 2023
Institution: Universidad de Chile
Role: Co-advisor

Name: Jorge Rojas
Degree Granted: Civil Engineering in Biotechnology, 2021
Program: Civil Engineering in Biotechnology
Thesis title: Isolation, Cultivation, and Differentiation of Adipose-Derived and Wharton’s Jelly Stem Cells for Use in Cell Therapy for Premature Ovarian Failure
Period: January - August 2021
Institution: Universidad de Chile
Role: Thesis committee member

Name: Lorna León
Degree Granted: Civil Engineering in Biotechnology, 2019
Program: Civil Engineering in Biotechnology
Thesis title: Suspension Culture of Mesenchymal Cells Derived from Adipose Tissue for Cell Therapy
Period: August 2018 - August 2019
Institution: Universidad de Chile
Role: Lab mentor and supervisor

2017-2020: Participante en el programa “Conoce la Ciencia”, proyecto de divulgación científica para estudiantes de Enseñanza media en CeBiB, Universidad de Chile.

Course Organization: "Animal Cell Technology: Development and Production of Biotherapeutics" (TCA), November 2024, Santiago, Chile.

Speaker at the Course: "Animal Cell Technology: Development and Production of Biotherapeutics" (TCA) – Presentation: "Expansion of Human MSCs in High-Density Suspension Cultures for Therapeutic Applications", November 2024, Chile.